Quant Healthcare Fund - Growth Option - Regular Plan
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 11-07-2023
AUM:
₹ 367.78 Cr
Expense Ratio
2.42%
Benchmark
BSE Healthcare TRI
ISIN
INF966L01CG3
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
200
Fund Manager
Sanjeev Sharma, Vasav Sahgal, Sandeep Tandon, Ankit A Pande
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - Growth Option - Regular Plan | 5.6 | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
14.6118
Last change
-0.08 (-0.581%)
Fund Size (AUM)
₹ 367.78 Cr
Performance
23.61% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Fund Manager
Sanjeev Sharma, Vasav Sahgal, Sandeep Tandon, Ankit A Pande
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 9.57 |
| RPG LIFE SCIENCES LIMITED EQ | 9.28 |
| ASTER DM HEALTHCARE LIMITED EQ | 9.22 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 7.42 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 7.31 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 7.2 |
| ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/- | 7.02 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 6.82 |
| RELIANCE INDUSTRIES LIMITED EQ | 6.69 |
| ZYDUS WELLNESS LIMITED EQ | 5.83 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 80.01 |
| Oil, Gas & Consumable Fuels | 6.69 |
| Fast Moving Consumer Goods | 5.83 |
| Telecommunication | 5.11 |
| N/A | 2.36 |